Case Report
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Oct 26, 2022; 10(30): 11016-11022
Published online Oct 26, 2022. doi: 10.12998/wjcc.v10.i30.11016
Two novel mutations in the VPS33B gene in a Chinese patient with arthrogryposis, renal dysfunction and cholestasis syndrome 1: A case report
Hui Yang, Shuang-Zhu Lin, Shi-Hui Guan, Wan-Qi Wang, Jia-Yi Li, Gui-Dan Yang, Su-Li Zhang
Hui Yang, Gui-Dan Yang, Su-Li Zhang, Department of Neonatology, Hainan Women and Children's Medical Center, Haikou 570100, Hainan Province, China
Shuang-Zhu Lin, Shi-Hui Guan, Diagnosis and Treatment Center for Children, The First Affiliated Hospital to Changchun University of Chinese Medicine, Changchun 130021, Jilin Province, China
Wan-Qi Wang, Jia-Yi Li, Changchun University of Chinese Medicine, Changchun 130000, Jilin Province, China
Author contributions: Yang H and Lin SZ collected and analyzed all clinical data and wrote the manuscript; Guan SH participated in collation of the literature and the chart research; Zhang SL was involved in the genetic diagnosis and treatment of the patients; Lin SZ, Wang WQ, Li JY and Yang GD substantially participated in drafting and revising the manuscript for important intellectual content; All authors involved have read and approved the final manuscript.
Supported by the Hainan Province Clinical Medical Center, No. (2021)75 and (2021)276.
Informed consent statement: Informed consent has been obtained from the patient’s family for all information mentioned in this report.
Conflict-of-interest statement: All the authors of this article have stated that there is no conflict of interest and have signed the relevant documents.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Su-Li Zhang, MD, Doctor, Department of Neonatology, Hainan Women and Children's Medical Center, No. 15 Longkun South Road, Haikou 570100, Hainan Province, China. 18389454649@163.com
Received: April 13, 2022
Peer-review started: April 13, 2022
First decision: July 11, 2022
Revised: July 27, 2022
Accepted: September 14, 2022
Article in press: September 14, 2022
Published online: October 26, 2022
Abstract
BACKGROUND

The VPS33B (OMIM: 608552) gene is located on chromosome 15q26.1. We found a female infant with autosomal recessive arthrogryposis, renal dysfunction and cholestasis syndrome 1 (ARCS1) caused by mutation in VPS33B. The child was diagnosed with ARCS1 (OMIM: 208085) after the whole exome sequencing revealed two heterozygous mutations (c.96+1G>C, c.242delT) in the VPS33B gene.

CASE SUMMARY

We report a Chinese female infant with neonatal cholestasis disorder, who was eventually diagnosed with ARCS1 by genetic analysis. Genetic testing revealed two new mutations (c.96+1G>C and c.242delT) in VPS33B, which is the causal gene. The patient was compound heterozygous, and her parents were both heterozygous.

CONCLUSION

This study extends the mutational spectrum of the VPS33B gene to provide a molecular basis for the etiological diagnosis of ARCS1 and for genetic counseling of the family.

Keywords: Arthrogryposis, renal dysfunction and cholestasis syndrome 1, VPS33B gene, Children, Heterozygous mutation, Case report

Core Tip: We report a Chinese female infant with neonatal cholestasis disorder, who was eventually diagnosed with arthrogryposis, renal dysfunction and cholestasis syndrome 1 by genetic analysis. Genetic testing revealed two new mutations (c.96+1G>C, c.242delT) in VPS33B, which are the causal genes. The patient was compound heterozygous, and her parents were both heterozygous. Our paper will expand the mutational spectrum of VPS33B.